Red and white patches Flashcards
Mucosa colour depends on…
epithelial thickness
keratinisation
vasculature
inflammation
melanin
white patches causes
increased keratin
abnormal
candida
Systemic RF for candida
Immunocompromised : Medication, Medical conditions
Deficiency states: Anaemia
Extremes of age
Local RF for candida
Hyposalivation
Smoking
broad-spectrum antimicrobials
Corticosteroids
Thrush/Yeast/Fungal infection
Antifungal Management of Candida
Fluconazole
Miconazole
Nystatin
Local Measures of Candida
Rinse after inhalers
Use a Spacer
Denture hygiene
Smoking cessation
Traumatic Keratosis
increased keratin at site
encourage smoking cessation
refer if high risk site/patient
OLP types
reticular
atrophic
papular
erosive
plaque like
bullous
OLP
CD8+ T Cell-mediated destruction of basal keratinocytes
asymptomatic
burning/stinging
generalised/idiopathic
malignant potential 1% over 10 years
OLR causing drugs
Antihypertensives
Antimalarials
NSAIDS
Allopurinol
Lithium
OLR causing materials
metals (gold, nickel)
OLP/OLR Management (symptomatic relief)
HSMW
L.A (lidocaine)
Avoid triggers ( spicy food, fizzy drink)
Steroid MW (betamethasone)
Beclomethasone MDI
Change restorations
Referral to OM
Hairy Leukoplakia
lateral border of tongue
para-keratin projections
acanthotic
Triggered by EBV
(20-25% HIV patients)
Leukoplakia
clinical diagnosis
malignant potential
can be dysplastic
need biopsy for histological diagnosis
Red patches
atrophic tissue (becomes thinner)
inflammation
patch with no known cause (high malignant potential)
Granulomatosis with polyangiitis
systemic vasculitis
fever and weight loss
92% have ENT manifestations
potentially fatal
management with immunosuppressants
Erythroplakia
velvety, firery, red patch
high malignant potential
URGENT REFERRAL
OFG and Oral Crohn’s
non necrotising granuloma formation
Consider GI Investigations
OFG and Oral Crohn’s Management
Topical steroids
Avoidance diets
Intralesional steroid
Biologics for Crohn’s disease
(Infliximab, adalimumab(Anti TNF), ustekinumab (Anti IL21/23, vedolizumab(Anti-a4b7))
Erythroleukoplakia
Speckled red and white patches
High malignant change potential
Erythroleukoplakia management
URGENT REFFERAL
Lesion assessment
location
colour
hard or soft (induration)
raised or flat
texture
symmetry
wipeable?
homo/heterogenity